
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Xylooligosaccharides (XOS) are prebiotic oligosaccharides that selectively promote the growth of beneficial Bifidobacteria in the gut. They work by resisting digestion in the small intestine and serving as a specific food source for beneficial bacteria in the colon.

Reported Benefits (Provisional)
Origin & History

Xylooligosaccharides are derived from the hydrolysis of xylan, a component of plant cell walls. They are commonly extracted from sources like corn cobs, sugarcane bagasse, and birchwood. The extraction process involves enzymatic treatment to break down xylan into shorter sugar chains.
Research Narrative (Provisional)
Research includes randomized controlled trials (RCTs) and in vitro studies showing benefits for gut health and lipid metabolism. Some studies indicate potential for enhancing mineral absorption.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Composed primarily of xylose sugar units. - Low-calorie, non-digestible carbohydrate. - Acts as a soluble fiber, contributing to dietary fiber intake.
Reported Mechanism (Provisional)
XOS resist hydrolysis by human digestive enzymes due to their β-1,4-glycosidic bonds between xylose units. Upon reaching the colon, they are selectively fermented by Bifidobacteria and Lactobacilli through specific β-xylosidase enzymes. This fermentation produces short-chain fatty acids including acetate, propionate, and butyrate, which lower colonic pH and inhibit pathogenic bacteria growth.
Clinical Narrative (Provisional)
Human studies demonstrate XOS doses of 1.4-8 grams daily significantly increase Bifidobacteria populations within 1-2 weeks. A randomized controlled trial with 32 participants showed 2.8g daily XOS increased beneficial bacteria by 10-fold and improved stool frequency. Multiple studies confirm XOS has superior bifidogenic effects compared to other prebiotics like inulin. However, most clinical trials are small-scale with fewer than 100 participants, requiring larger studies for definitive health claims.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







